We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
-6.37%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$3.55B
AUM Growth
-$772M
Cap. Flow
-$469M
Cap. Flow %
-13.21%
Top 10 Hldgs %
58.31%
Holding
161
New
16
Increased
39
Reduced
56
Closed
15

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$126M
2
TCOM icon
Trip.com Group
TCOM
+$77.7M
3
ICVX
Icosavax, Inc. Common Stock
ICVX
+$26.7M
4
BTRS
BTRS Holdings Inc. Class 1 Common Stock
BTRS
+$23.5M
5
IDYA icon
IDEAYA Biosciences
IDYA
+$21.6M

Top Sells

Rank Stock Value
1
ALLY icon
Ally Financial
ALLY
+$177M
2
LPX icon
Louisiana-Pacific
LPX
+$118M
3
WAB icon
Wabtec
WAB
+$106M
4
AEO icon
American Eagle Outfitters
AEO
+$102M
5
YUMC icon
Yum China
YUMC
+$52M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Industrials 21.06%
3 Consumer Discretionary 20.58%
4 Healthcare 13.81%
5 Materials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
101
Cisco
CSCO
$490B
$1.94M 0.05%
35,700
– –
INFI
102
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$1.87M 0.05%
545,508
+18,407
+3% +$56.7K
BCRX icon
103
BioCryst Pharmaceuticals
BCRX
$2.45B
$1.86M 0.05%
129,688
-39,027
-23% -$615K
AAPL icon
104
Apple
AAPL
$4.48T
$1.81M 0.05%
12,788
– –
INFO
105
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.67M 0.05%
14,338
-5,122
-26% -$605K
BCAB icon
106
BioAtla
BCAB
$5.74M
$1.67M 0.05%
1,133
+459
+68% +$894K
EBAY icon
107
eBay
EBAY
$47.7B
$1.58M 0.04%
22,679
– –
ASLN
108
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
$1.58M 0.04%
22,172
– –
DNLI icon
109
Denali Therapeutics
DNLI
$3.91B
$1.55M 0.04%
30,791
– –
ALEC icon
110
Alector
ALEC
$192M
$1.49M 0.04%
65,380
-14,504
-18% -$406K
LOGC
111
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$1.47M 0.04%
+320,273
New +$1.41M
XLNX
112
DELISTED
Xilinx Inc
XLNX
$1.39M 0.04%
9,209
– –
ELUT icon
113
Elutia
ELUT
$38.5M
$1.36M 0.04%
195,809
– –
ARCT icon
114
Arcturus Therapeutics
ARCT
$210M
$1.35M 0.04%
28,300
– –
OMIC
115
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$1.2M 0.03%
3,574
+3,541
+10,730% +$1.82M
MRSN
116
DELISTED
Mersana Therapeutics
MRSN
$1.05M 0.03%
4,436
– –
INTC icon
117
Intel
INTC
$493B
$839K 0.02%
15,750
-524
-3% -$28.4K
LUMN icon
118
Lumen
LUMN
$6.6B
$755K 0.02%
60,907
– –
MSI icon
119
Motorola Solutions
MSI
$75.9B
$655K 0.02%
2,818
– –
CGNT icon
120
Cognyte Software
CGNT
$679M
$586K 0.02%
+28,506
New +$729K
LUXE
121
LuxExperience B.V.
LUXE
$1.12B
$541K 0.02%
20,118
– –
TWLO icon
122
Twilio
TWLO
$37.8B
$474K 0.01%
1,486
– –
LBTYA icon
123
Liberty Global Class A
LBTYA
$3.49B
$441K 0.01%
14,800
– –
INOV
124
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$355K 0.01%
8,800
– –
NLSN
125
DELISTED
Nielsen Holdings plc
NLSN
$326K 0.01%
17,000
– –
3 4
5
6 7

Similar funds

LCG
Lisanti Capital Growth New York $397M AUM 178.66% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
GPC
Greenstone Partners & Co Larkspur, California $395M AUM 35.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Platinum Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Platinum Investment Management held 161 positions worth $3.55B, down 18% from $4.32B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Platinum Investment Management withdrew a net $469M in Q3 2021, closing 15 positions and reducing 56 holdings. Its most notable exit was Wabtec, an estimated $106M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Platinum Investment Management opened a new position in Icosavax, Inc. Common Stock worth $23.3M.

  • Platinum Investment Management's largest Q3 2021 buy was Icosavax, Inc. Common Stock: 786,575 shares worth $23.3M.
  • Platinum Investment Management added most to Alibaba in Q3 2021, an estimated $126M increase.
  • Platinum Investment Management's biggest Q3 2021 reduction was Ally Financial, cutting an estimated $177M.
  • Platinum Investment Management fully exited Wabtec in Q3 2021, selling an estimated $106M.
  • Platinum Investment Management's ten largest holdings make up 58% of its $3.55B portfolio in Q3 2021.
  • Platinum Investment Management opened 16 new positions and closed 15 in Q3 2021.
  • Platinum Investment Management's portfolio value fell 18% quarter-over-quarter to $3.55B.

Based on Platinum Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.